Provided by Tiger Fintech (Singapore) Pte. Ltd.

Genfit S.A.

3.51
+0.0000
Volume:415.00
Turnover:1.44K
Market Cap:175.03M
PE:7.50
High:3.51
Open:3.51
Low:3.51
Close:3.51
Loading ...

Company Profile

Company Name:
Genfit S.A.
Exchange:
NASDAQ
Establishment Date:
1999
Employees:
169
Office Location:
Parc EurasantE,885, avenue EugEne AvinEe,Loos,Nord-Pas-de-Calais,France
Zip Code:
59120
Fax:
33 2 20 16 40 01
Introduction:
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.

Directors

Name
Position
Jean Francois Mouney
Chief Executive Officer and Chairman of the Board
Xavier Guille des Buttes
Vice-Chairman of the Board
Laurent Lannoo
Corporate Secretary, Director of Legal Affairs
Anne Helene Monsellato
Director
Catherine Larue
Director
Florence Sejourne
Director
Frederic Desdouits
Director
Philippe Moons
Director

Shareholders

Name
Position
Jean Francois Mouney
Chief Executive Officer and Chairman of the Board
Dean Hum
Chief Operating Officer
Jean Christophe Marcoux
Chief Strategy Officer
Laurent Lannoo
Corporate Secretary, Director of Legal Affairs
Nathalie Huitorel
Executive Vice President and Chief Financial and Administrative Officer
Pascal Prigent
Executive Vice President, Marketing and Commercial Development